GALECTIN THERAPEUTICS INC - COMMON STOCK (GALT)

CUSIP: 363225202

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+70,119
Put/Call ratio
4.7%
SEC-reported price per share
$2.10
Number of holders
55
Value change
+$222,174
Number of buys
14
Open additional details 1 more signal available
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
110,899,890

Security key

363225202

Report period

Q1 2023

Institutions

55

Top holders

10

Ownership snapshot

Top reported holders of GALT - GALECTIN THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F Highest disclosed value: $2,194,295 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $2.19M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $2.19M
OSAIC HOLDINGS, INC. $1.44M
BlackRock Finance, Inc. $871.3K
GEODE CAPITAL MANAGEMENT, LLC $580K
Geneos Wealth Management Inc. $491.3K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$2,194,295
1,941,854 shares
— 31 Dec 2022
OSAIC HOLDINGS, INC.
13F
Company
13F
—
denominator unverified
$1,436,165
1,270,328 shares
— 31 Dec 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$871,325
771,083 shares
— 31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$580,000
513,815 shares
— 31 Dec 2022
Geneos Wealth Management Inc.
13F
Company
13F
—
denominator unverified
$491,324
434,800 shares
— 31 Dec 2022
Atria Wealth Solutions, Inc.
13F
Company
13F
—
denominator unverified
$305,891
270,700 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
55
Shares
7,155,735
Rows available
55
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
55
Q1 2023 holders
55
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .